Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | XYL | Common Stock | Options Exercise | $63.6K | +1K | +2.69% | $63.55 | 38.2K | Jan 3, 2022 | Direct | |
transaction | XYL | Common Stock | Sale | -$120K | -1K | -2.62% | $120.21 | 37.2K | Jan 3, 2022 | Direct | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | XYL | Stock Option (Right to Buy) | Options Exercise | $0 | -1K | -2.47% | $0.00 | 39.4K | Jan 3, 2022 | Common | 1K | $63.55 | Direct | F3 |
Id | Content |
---|---|
F1 | The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on March 15, 2021. |
F2 | This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. |
F3 | The May 7, 2020 option grant vests in one third increments on May 7, 2021, May 7, 2022 and May 7, 2023. |